1. Home
  2. HIPO vs SYRE Comparison

HIPO vs SYRE Comparison

Compare HIPO & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HIPO
  • SYRE
  • Stock Information
  • Founded
  • HIPO 2015
  • SYRE 2013
  • Country
  • HIPO United States
  • SYRE United States
  • Employees
  • HIPO N/A
  • SYRE N/A
  • Industry
  • HIPO Property-Casualty Insurers
  • SYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • HIPO Finance
  • SYRE Health Care
  • Exchange
  • HIPO Nasdaq
  • SYRE Nasdaq
  • Market Cap
  • HIPO 923.0M
  • SYRE 1.1B
  • IPO Year
  • HIPO N/A
  • SYRE 2016
  • Fundamental
  • Price
  • HIPO $32.60
  • SYRE $26.84
  • Analyst Decision
  • HIPO Strong Buy
  • SYRE Strong Buy
  • Analyst Count
  • HIPO 5
  • SYRE 4
  • Target Price
  • HIPO $35.40
  • SYRE $52.67
  • AVG Volume (30 Days)
  • HIPO 278.3K
  • SYRE 631.2K
  • Earning Date
  • HIPO 11-05-2025
  • SYRE 11-04-2025
  • Dividend Yield
  • HIPO N/A
  • SYRE N/A
  • EPS Growth
  • HIPO N/A
  • SYRE N/A
  • EPS
  • HIPO 3.71
  • SYRE N/A
  • Revenue
  • HIPO $450,000,000.00
  • SYRE N/A
  • Revenue This Year
  • HIPO $27.93
  • SYRE N/A
  • Revenue Next Year
  • HIPO $22.04
  • SYRE N/A
  • P/E Ratio
  • HIPO $8.70
  • SYRE N/A
  • Revenue Growth
  • HIPO 34.41
  • SYRE N/A
  • 52 Week Low
  • HIPO $19.92
  • SYRE $10.91
  • 52 Week High
  • HIPO $38.98
  • SYRE $29.06
  • Technical
  • Relative Strength Index (RSI)
  • HIPO 44.00
  • SYRE 69.86
  • Support Level
  • HIPO $31.27
  • SYRE $23.01
  • Resistance Level
  • HIPO $34.59
  • SYRE $25.42
  • Average True Range (ATR)
  • HIPO 2.04
  • SYRE 1.61
  • MACD
  • HIPO -0.18
  • SYRE 0.07
  • Stochastic Oscillator
  • HIPO 25.84
  • SYRE 98.69

About HIPO Hippo Holdings Inc.

Hippo Holdings Inc is a home insurance group that created a new standard of care and protection for homeowners. It provides insurance for computers, home offices, electronics, appliances, water backup, and service line coverage, among others. It has three reportable segments Services segment earns fees and commission income without assuming underwriting risk or need for reinsurance, Insurance-as-a-Service managed through the company's subsidiary Spinnaker is a platform to support third-party MGAs, and the Hippo Home Insurance Program engaged in homeowners insurance business. It generates the majority of its revenue from the Insurance-as-a-Service segment.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: